Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali

NCT02942277 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

301

Enrollment

NIH

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: Pfs25M-EPA
BIOLOGICAL: Pfs230D1M-EPA
OTHER: AS01
BIOLOGICAL: Engerix-B
BIOLOGICAL: Menactra
OTHER: Normal Saline
DRUG: Coartem

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)